User contributions
- 17:32, 22 November 2024 diff hist +6,638 N Boyettekirkland3012 Created page with "010). Savolitinib and crizotinib did not improve PFS compared with sunitinib. Grade 3 or 4 adverse events occurred in 31 (69%) of 45 patients receiving sunitinib, 32 (74%) of..." current